BSE - Free Realtime Quote INR
Indrayani Biotech Limited (INDRANIB.BO)
18.72
0.00
(0.00%)
As of April 30 at 3:15:00 PM GMT+5:30. Market Open.
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
1,240,393
1,662,256
1,629,279
615,718
210,884
Cost of Revenue
626,014
971,325
1,022,144
410,429
157,715
Gross Profit
614,379
690,931
607,135
205,289
53,169
Operating Expense
450,949
492,377
467,407
144,041
102,290
Operating Income
163,430
198,554
139,728
61,248
-49,121
Net Non Operating Interest Income Expense
-102,185
-98,974
-20,888
-17,763
-18,112
Pretax Income
73,085
109,744
123,059
44,519
-112,144
Tax Provision
7,092
5,519
3,752
124
--
Net Income Common Stockholders
37,557
63,649
87,368
44,395
-112,144
Diluted NI Available to Com Stockholders
37,557
63,649
87,368
44,395
-112,144
Basic EPS
0.87
1.63
2.55
1.30
-3.15
Diluted EPS
0.87
1.63
2.05
1.30
-3.15
Basic Average Shares
101,652.47
38,927
34,227
34,227
35,601.27
Diluted Average Shares
101,652.47
38,927
43,477
34,227
35,601.27
Rent Expense Supplemental
36
10,876
8,576
3,935
4,256
Total Expenses
1,076,963
1,463,702
1,489,551
554,470
260,005
Net Income from Continuing & Discontinued Operation
37,557
63,649
87,368
44,395
-112,144
Normalized Income
37,557
63,649
91,710.44
44,395
-66,179
Interest Income
--
1,985
35,538
1,142
1,594
Interest Expense
102,036
98,825
49,992
18,261
19,078
Net Interest Income
-102,185
-98,974
-20,888
-17,763
-18,112
EBIT
175,121
208,569
173,051
62,780
-93,066
EBITDA
235,553
246,622
206,522
69,374
-88,484
Reconciled Cost of Revenue
626,014
971,325
1,022,144
410,429
157,715
Reconciled Depreciation
60,432
38,053
33,471
6,594
4,582
Net Income from Continuing Operation Net Minority Interest
37,557
63,649
87,368
44,395
-112,144
Total Unusual Items Excluding Goodwill
--
--
-4,479
--
-45,965
Total Unusual Items
--
--
-4,479
--
-45,965
Normalized EBITDA
235,553
246,622
211,001
69,374
-42,519
Tax Rate for Calcs
0
0
0
0
--
Tax Effect of Unusual Items
--
--
-136.56
--
--
3/31/2021 - 12/30/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade